{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:26:11Z","timestamp":1793676371212,"version":"4.5.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangzhou Institute of Cancer Research, and the Guangdong Basic and Applied Basic Research Foundation","award":["2024A1515011956 and 2026A1515010381"],"award-info":[{"award-number":["2024A1515011956 and 2026A1515010381"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572348 and 82101994"],"award-info":[{"award-number":["82572348 and 82101994"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00259-026-08163-z","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:53:35Z","timestamp":1787986415000},"page":"8433-8447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["[18F]FAPI-04 PET\/CT for detection of recurrent breast cancer after surgery: a post hoc analysis comparing [18F]FDG PET\/CT"],"prefix":"10.1007","volume":"53","author":[{"given":"Hao","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiucen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0607-6300","authenticated-orcid":false,"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"8163_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"Cancer J Clin"},{"key":"8163_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. 2019;321:288\u2013300. https:\/\/doi.org\/10.1001\/jama.2018.19323.","journal-title":"JAMA"},{"key":"8163_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat reviews Disease primers. 2019;5:66. https:\/\/doi.org\/10.1038\/s41572-019-0111-2.","journal-title":"Nat reviews Disease primers"},{"key":"8163_CR4","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/s0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet (London England). 2011;378:1707\u201316. https:\/\/doi.org\/10.1016\/s0140-6736(11)61629-2.","journal-title":"Lancet (London England)"},{"key":"8163_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513\u201320. https:\/\/doi.org\/10.1056\/NEJMoa0906260.","journal-title":"N Engl J Med"},{"key":"8163_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10549-008-0023-4","volume":"114","author":"WL Lu","year":"2009","unstructured":"Lu WL, Jansen L, Post WJ, Bonnema J, Van de Velde JC, De Bock GH. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2009;114:403\u201312. https:\/\/doi.org\/10.1007\/s10549-008-0023-4.","journal-title":"Breast Cancer Res Treat"},{"key":"8163_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00330-025-11819-3","volume":"36","author":"E Giannotti","year":"2026","unstructured":"Giannotti E, Pasculli M, Sella T, Van Ongeval C, Marcon M, Lesaru M, et al. ESR Essentials: post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging. Eur Radiol. 2026;36:837\u201349. https:\/\/doi.org\/10.1007\/s00330-025-11819-3.","journal-title":"Eur Radiol"},{"key":"8163_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2214\/ajr.16.16300","volume":"208","author":"DL Lam","year":"2017","unstructured":"Lam DL, Houssami N, Lee JM. Imaging Surveillance After Primary Breast Cancer Treatment. AJR Am J Roentgenol. 2017;208:676\u201386. https:\/\/doi.org\/10.2214\/ajr.16.16300.","journal-title":"AJR Am J Roentgenol"},{"key":"8163_CR9","doi-asserted-by":"publisher","first-page":"e230070","DOI":"10.1148\/rg.230070","volume":"44","author":"JN Thai","year":"2024","unstructured":"Thai JN, Sodagari F, Colwell AS, Winograd JM, Revzin MV, Mahmoud H, et al. Multimodality imaging of postmastectomy breast reconstruction techniques, complications, and tumor recurrence. Radiographics: Rev publication Radiological Soc North Am Inc. 2024;44:e230070. https:\/\/doi.org\/10.1148\/rg.230070.","journal-title":"Radiographics: Rev publication Radiological Soc North Am Inc"},{"key":"8163_CR10","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1007\/s00259-024-06696-9","volume":"51","author":"SC Vaz","year":"2024","unstructured":"Vaz SC, Woll JPP, Cardoso F, Groheux D, Cook GJR, Ulaner GA, et al. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET\/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI\/ESR, and EUSOMA). Eur J Nucl Med Mol Imaging. 2024;51:2706\u201332. https:\/\/doi.org\/10.1007\/s00259-024-06696-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8163_CR11","doi-asserted-by":"publisher","first-page":"W304","DOI":"10.2214\/ajr.11.7130","volume":"198","author":"M Adejolu","year":"2012","unstructured":"Adejolu M, Huo L, Rohren E, Santiago L, Yang WT. False-positive lesions mimicking breast cancer on FDG PET and PET\/CT. AJR Am J Roentgenol. 2012;198:W304\u201314. https:\/\/doi.org\/10.2214\/ajr.11.7130.","journal-title":"AJR Am J Roentgenol"},{"key":"8163_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1053\/j.semnuclmed.2021.04.005","volume":"51","author":"EG Kikano","year":"2021","unstructured":"Kikano EG, Avril S, Marshall H, Jones RS, Montero AJ, Avril N. PET\/CT Variants and Pitfalls in Breast Cancers. Semin Nucl Med. 2021;51:474\u201384. https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.04.005.","journal-title":"Semin Nucl Med"},{"key":"8163_CR13","doi-asserted-by":"publisher","unstructured":"K\u00f6mek H, Can C, G\u00fczel Y, Oru\u00e7 Z, G\u00fcndo\u011fan C, Yildirim \u00d6A et al. [68Ga]FAPI-04 PET\/CT, a new step in breast cancer imaging: a comparative pilot study with the [18F]FDG PET\/CT. Annals of nuclear medicine. 2021;35:744\u201352. https:\/\/doi.org\/10.1007\/s12149-021-01616-5","DOI":"10.1007\/s12149-021-01616-5"},{"key":"8163_CR14","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00259-025-07108-2","volume":"52","author":"W Guo","year":"2025","unstructured":"Guo W, Xu W, Meng T, Fan C, Fu H, Pang Y, et al. FAP-targeted PET\/CT imaging in patients with breast cancer from a prospective bi-center study: Insights into diagnosis and clinic management. Eur J Nucl Med Mol Imaging. 2025;52:2317\u201334. https:\/\/doi.org\/10.1007\/s00259-025-07108-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8163_CR15","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1097\/rlu.0000000000004751","volume":"48","author":"G Al\u00e7\u0131n","year":"2023","unstructured":"Al\u00e7\u0131n G, Arslan E, Aksoy T, Cin M, Erol Fenercio\u011flu \u00d6, Beyhan E, et al. [68Ga]FAPI-04 PET\/CT in Selected breast cancer patients with low FDG affinity: A head-to-head comparative study. Clin Nucl Med. 2023;48:e420\u201330. https:\/\/doi.org\/10.1097\/rlu.0000000000004751.","journal-title":"Clin Nucl Med"},{"key":"8163_CR16","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1007\/s00259-026-07766-w","volume":"53","author":"W Liu","year":"2026","unstructured":"Liu W, Zhang N, Zheng W, Xu T, Huang D, Liu Z, et al. Comparative evaluation of [68Ga]Ga-FAP-2286 and [18F]FDG PET\/CT in breast cancer and initial experience with [177Lu]Lu-FAP-2286 therapy. Eur J Nucl Med Mol Imaging. 2026;53:3749\u201359. https:\/\/doi.org\/10.1007\/s00259-026-07766-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8163_CR17","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00259-020-05146-6","volume":"48","author":"L Zhao","year":"2021","unstructured":"Zhao L, Pang Y, Luo Z, Fu K, Yang T, Zhao L, et al. Role of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2021;48:1944\u201355. https:\/\/doi.org\/10.1007\/s00259-020-05146-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8163_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2967\/jnumed.123.266329","volume":"65","author":"W Xu","year":"2024","unstructured":"Xu W, Cai J, Peng T, Meng T, Pang Y, Sun L, et al. Fibroblast Activation Protein-Targeted PET\/CT with 18F-Fibroblast activation protein inhibitor-74 for evaluation of gastrointestinal cancer: Comparison with [18F]FDG PET\/CT. J Nucl Med. 2024;65:40\u201351. https:\/\/doi.org\/10.2967\/jnumed.123.266329.","journal-title":"J Nucl Med"},{"key":"8163_CR19","doi-asserted-by":"publisher","first-page":"e222785","DOI":"10.1148\/radiol.222785","volume":"308","author":"Y Wei","year":"2023","unstructured":"Wei Y, Ma L, Li P, Lu J, Ren J, Yan S, et al. FAPI Compared with FDG PET\/CT for Diagnosis of primary and metastatic lung cancer. Radiology. 2023;308:e222785. https:\/\/doi.org\/10.1148\/radiol.222785.","journal-title":"Radiology"},{"key":"8163_CR20","volume-title":"AJCC Cancer Staging Manual","author":"MBES Amin","year":"2017","unstructured":"Amin MBES, Greene FL, et al. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.","edition":"8"},{"key":"8163_CR21","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1038\/s41467-024-47068-z","volume":"15","author":"H Croizer","year":"2024","unstructured":"Croizer H, Mhaidly R, Kieffer Y, Gentric G, Djerroudi L, Leclere R, et al. Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer. Nat Commun. 2024;15:2806. https:\/\/doi.org\/10.1038\/s41467-024-47068-z.","journal-title":"Nat Commun"},{"key":"8163_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13058-020-01311-9","volume":"22","author":"C Bonneau","year":"2020","unstructured":"Bonneau C, Eli\u00e8s A, Kieffer Y, Bourachot B, Ladoire S, Pelon F, et al. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer. Breast cancer research: BCR. 2020;22:76. https:\/\/doi.org\/10.1186\/s13058-020-01311-9.","journal-title":"Breast cancer research: BCR"},{"key":"8163_CR23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1053\/j.semnuclmed.2023.02.001","volume":"53","author":"M Bentestuen","year":"2023","unstructured":"Bentestuen M, Al-Obaydi N, Zacho HD. FAPI-avid nonmalignant PET\/CT findings: An expedited systematic review. Semin Nucl Med. 2023;53:694\u2013705. https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.02.001.","journal-title":"Semin Nucl Med"},{"key":"8163_CR24","doi-asserted-by":"publisher","first-page":"1339050","DOI":"10.3389\/fonc.2024.1339050","volume":"14","author":"M Janani","year":"2024","unstructured":"Janani M, Poorkhani A, Amiriani T, Donyadideh G, Ahmadi F, Jorjanisorkhankalateh Y, et al. Association of future cancer metastases with fibroblast activation protein-\u03b1: a systematic review and meta-analysis. Front Oncol. 2024;14:1339050. https:\/\/doi.org\/10.3389\/fonc.2024.1339050.","journal-title":"Front Oncol"},{"key":"8163_CR25","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/s1470-2045(20)30472-1","volume":"21","author":"PM Poortmans","year":"2020","unstructured":"Poortmans PM, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V, et al. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial. Lancet Oncol. 2020;21:1602\u201310. https:\/\/doi.org\/10.1016\/s1470-2045(20)30472-1.","journal-title":"Lancet Oncol"},{"key":"8163_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.acra.2024.07.058","volume":"32","author":"J Bin","year":"2025","unstructured":"Bin J, Wenjia L, Wan W, Kaiyin M, Bowen Y, Qichang W, et al. Comparison of [18F]FDG PET\/CT and [18F]FAPI PET\/CT in Systemic staging of newly diagnosed breast cancer. Acad Radiol. 2025;32:50\u20137. https:\/\/doi.org\/10.1016\/j.acra.2024.07.058.","journal-title":"Acad Radiol"},{"key":"8163_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/pro6.1245","volume":"8","author":"J Qin","year":"2024","unstructured":"Qin J, Zhao J, Yu J, Wei Y. [18F]NOTA-FAPI-04 PET\/CT downgraded the staging of a breast cancer patient and changed their treatment management. Precision radiation Oncol. 2024;8:227\u201331. https:\/\/doi.org\/10.1002\/pro6.1245.","journal-title":"Precision radiation Oncol"},{"key":"8163_CR28","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1097\/rlu.0000000000003594","volume":"46","author":"C G\u00fcndo\u011fan","year":"2021","unstructured":"G\u00fcndo\u011fan C, G\u00fczel Y, Can C, Alabalik U, K\u00f6mek H. False-Positive [68Ga]Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient With Breast Cancer. Clin Nucl Med. 2021;46:e433\u20135. https:\/\/doi.org\/10.1097\/rlu.0000000000003594.","journal-title":"Clin Nucl Med"},{"key":"8163_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4149\/neo_2020_200905N951","volume":"68","author":"H Li","year":"2021","unstructured":"Li H, Lin X, Yang D, Chen Z, Wang X, Re F, et al. Cancer-associated fibroblasts support bone tropic metastasis by acting as coordinators between the tumor microenvironment and bone matrix in breast cancer. Neoplasma. 2021;68:10\u201322. https:\/\/doi.org\/10.4149\/neo_2020_200905N951.","journal-title":"Neoplasma"},{"key":"8163_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12967-015-0587-9","volume":"13","author":"HM Kim","year":"2015","unstructured":"Kim HM, Jung WH, Koo JS. Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: An immunohistochemical analysis. J translational Med. 2015;13:222. https:\/\/doi.org\/10.1186\/s12967-015-0587-9.","journal-title":"J translational Med"},{"key":"8163_CR31","doi-asserted-by":"publisher","unstructured":"Manuppella F, Pisano G, Taralli S, Caldarella C, Calcagni ML. Diagnostic Performances of PET\/CT Using fibroblast activation protein inhibitors in patients with primary and metastatic liver tumors: A comprehensive literature review. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25137197.","DOI":"10.3390\/ijms25137197"},{"key":"8163_CR32","doi-asserted-by":"publisher","unstructured":"Ballal S, Yadav MP, Roesch F, Wakade N, Raju S, Sheokand P, et al. Head-to-Head Comparison between [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET\/CT Imaging in Patients with Breast Cancer. Pharmaceuticals (Basel Switzerland). 2023;16. https:\/\/doi.org\/10.3390\/ph16040521.","DOI":"10.3390\/ph16040521"},{"key":"8163_CR33","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s00259-022-05818-5","volume":"49","author":"X Zhou","year":"2022","unstructured":"Zhou X, Wang S, Xu X, Meng X, Zhang H, Zhang A, et al. Higher accuracy of [68Ga]Ga-DOTA-FAPI-04 PET\/CT comparing with 2-[18F]FDG PET\/CT in clinical staging of NSCLC. Eur J Nucl Med Mol Imaging. 2022;49:2983\u201393. https:\/\/doi.org\/10.1007\/s00259-022-05818-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8163_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.7150\/ijbs.72218","volume":"19","author":"H Wu","year":"2023","unstructured":"Wu H, Xiang Z, Huang G, He Q, Song J, Dou R, et al. BGN\/FAP\/STAT3 positive feedback loop mediated mutual interaction between tumor cells and mesothelial cells contributes to peritoneal metastasis of gastric cancer. Int J Biol Sci. 2023;19:465\u201383. https:\/\/doi.org\/10.7150\/ijbs.72218.","journal-title":"Int J Biol Sci"},{"key":"8163_CR35","doi-asserted-by":"publisher","first-page":"114527","DOI":"10.1016\/j.bcp.2021.114527","volume":"188","author":"M Huang","year":"2021","unstructured":"Huang M, Fu M, Wang J, Xia C, Zhang H, Xiong Y, et al. TGF-\u03b21-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-\u03b1. Biochem Pharmacol. 2021;188:114527. https:\/\/doi.org\/10.1016\/j.bcp.2021.114527.","journal-title":"Biochem Pharmacol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08163-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08163-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08163-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:30:12Z","timestamp":1793673012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08163-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":35,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8163"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08163-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This clinical study was performed in line with the principles of the Declaration of Helsinki and was registered on clinicaltrials.gov (NCT 05485792). Approval was granted by the Ethics Committee of Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University (ethics committee approval no. IIT-2022\u2013015#HYX#). Invasive diagnostic procedures, such as biopsy or surgical sampling, were primarily performed for lesions that were indeterminate on imaging. These procedures were determined following a multidisciplinary tumor board (MDT) consensus, which involved breast surgeons, radiologists, and nuclear medicine specialists, and were conducted after explicit patient re-consent. The MDT protocol prioritized lesion accessibility, clinical urgency, and patient safety, in accordance with the ethical guidelines set forth by the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants (signed by participant, parent, or legal representative) included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinicaltrials.gov: NCT 05485792.","order":3,"name":"Ethics","label":"Trial registration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}